Focal One
Payments companies reported to CMS as associated with Focal One. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Focal One, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Focal One
These are the largest totals companies reported as associated with Focal One. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kyrollis Attalla | New York, NY | Urology | $226,966.96 |
| Amir Lebastchi | Los Angeles, CA | Urology | $178,776.01 |
| Nitin Yerram | Hackensack, NJ | Urology | $41,027.22 |
| Cary Robertson | Durham, NC | Urology | $33,300.51 |
| George Schade | Seattle, WA | Urology | $26,628.84 |
| David Finley | Los Angeles, CA | Urology | $25,594.04 |
| Alexander Cole | Boston, MA | Urology | $25,143.32 |
| James Wysock | Flushing, NY | Urology | $23,574.69 |
| Gerard Henry | Bossier City, LA | Urology | $21,195.49 |
| Alon Lazarovich | Chicago, IL | Urology | $20,558.54 |
Prescribed Focal One?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.